Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer. Chou J, Egusa EA, Wang S, Badura ML, et al. Cancer Res 2022 Nov 9. pii: 710533. doi: 10.1158/0008-5472.CAN-22-1433.

Read + Share

Amedeo Smart

Independent Medical Education

Chou J, Egusa EA, Wang S, Badura ML, et al. Immunotherapeutic targeting and PET imaging of DLL3 in small cell neuroendocrine prostate cancer. Cancer Res 2022 Nov 9. pii: 710533. doi: 10.1158/0008-5472.CAN-22-1433.
PMID: 36351060